Export Ready — 

Urothelial bladder cancer progression: lessons learned from the bench

Bibliographic Details
Main Author: Baltazar, Fátima
Publication Date: 2014
Other Authors: Afonso, Julieta Alexandra Pereira, Longatto Filho, Adhemar, Reis, R. M.
Format: Article
Language: por
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/1822/40239
Summary: Urothelial bladder carcinoma (UBC) is an intricate malignancy with a variable natural history and clinical behavior. Despite developments in diagnosis/prognosis refinement and treatment modalities, the recurrence rate is high, and progression from non-muscle to muscle invasive UBC commonly leads to metastasis. Moreover, patients with muscle-invasive or extra-vesical disease often fail the standard chemotherapy treatment, and overall survival rates are poor. Thus, UBC remains a challenge in the oncology field, representing an ideal candidate for research on biomarkers that could identify patients at increased risk of recurrence, progression, and chemo-refractoriness. However, progress toward personalized medicine has been hampered by the unique genetic complexity of UBC. Recent genome-wide expression and sequencing studies have brought new insights into its molecular features, pathogenesis and clinical diversity, revealing a landscape where classical pathology is intersected by the novel and heterogeneous molecular groups. Hence, it seems plausible to postulate that only an integrated signature of prognostic/predictive biomarkers inherent in different cancer hallmarks will reach clinical validation. In this review, we have summarized ours and others' research into novel putative biomarkers of progression and chemoresistance that encompass several hallmarks of cancer: tumor neovascularization, invasion and metastasis, and energy metabolism reprogramming of the tumor microenvironment.
id RCAP_e564f6f650676c1849b96c3d0ffc485b
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/40239
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Urothelial bladder cancer progression: lessons learned from the benchCD147Lymphovascular invasionMammalian target of rapamycinMonocarboxylate transportersProgressionRaf kinase inhibitor proteinScoring systemUrothelial bladder cancerUrothelial bladder carcinoma (UBC) is an intricate malignancy with a variable natural history and clinical behavior. Despite developments in diagnosis/prognosis refinement and treatment modalities, the recurrence rate is high, and progression from non-muscle to muscle invasive UBC commonly leads to metastasis. Moreover, patients with muscle-invasive or extra-vesical disease often fail the standard chemotherapy treatment, and overall survival rates are poor. Thus, UBC remains a challenge in the oncology field, representing an ideal candidate for research on biomarkers that could identify patients at increased risk of recurrence, progression, and chemo-refractoriness. However, progress toward personalized medicine has been hampered by the unique genetic complexity of UBC. Recent genome-wide expression and sequencing studies have brought new insights into its molecular features, pathogenesis and clinical diversity, revealing a landscape where classical pathology is intersected by the novel and heterogeneous molecular groups. Hence, it seems plausible to postulate that only an integrated signature of prognostic/predictive biomarkers inherent in different cancer hallmarks will reach clinical validation. In this review, we have summarized ours and others' research into novel putative biomarkers of progression and chemoresistance that encompass several hallmarks of cancer: tumor neovascularization, invasion and metastasis, and energy metabolism reprogramming of the tumor microenvironment.OAE Publishing Inc. (OAE)Universidade do MinhoBaltazar, FátimaAfonso, Julieta Alexandra PereiraLongatto Filho, AdhemarReis, R. M.2014-12-182014-12-18T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/40239por2394-4722http://www.jcmtjournal.com/article.asp?issn=2394-4722;year=2015;volume=1;issue=2;spage=57;epage=66;aulast=Afonsoinfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2024-05-11T06:16:05Zoai:repositorium.sdum.uminho.pt:1822/40239Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T15:47:07.141500Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Urothelial bladder cancer progression: lessons learned from the bench
title Urothelial bladder cancer progression: lessons learned from the bench
spellingShingle Urothelial bladder cancer progression: lessons learned from the bench
Baltazar, Fátima
CD147
Lymphovascular invasion
Mammalian target of rapamycin
Monocarboxylate transporters
Progression
Raf kinase inhibitor protein
Scoring system
Urothelial bladder cancer
title_short Urothelial bladder cancer progression: lessons learned from the bench
title_full Urothelial bladder cancer progression: lessons learned from the bench
title_fullStr Urothelial bladder cancer progression: lessons learned from the bench
title_full_unstemmed Urothelial bladder cancer progression: lessons learned from the bench
title_sort Urothelial bladder cancer progression: lessons learned from the bench
author Baltazar, Fátima
author_facet Baltazar, Fátima
Afonso, Julieta Alexandra Pereira
Longatto Filho, Adhemar
Reis, R. M.
author_role author
author2 Afonso, Julieta Alexandra Pereira
Longatto Filho, Adhemar
Reis, R. M.
author2_role author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Baltazar, Fátima
Afonso, Julieta Alexandra Pereira
Longatto Filho, Adhemar
Reis, R. M.
dc.subject.por.fl_str_mv CD147
Lymphovascular invasion
Mammalian target of rapamycin
Monocarboxylate transporters
Progression
Raf kinase inhibitor protein
Scoring system
Urothelial bladder cancer
topic CD147
Lymphovascular invasion
Mammalian target of rapamycin
Monocarboxylate transporters
Progression
Raf kinase inhibitor protein
Scoring system
Urothelial bladder cancer
description Urothelial bladder carcinoma (UBC) is an intricate malignancy with a variable natural history and clinical behavior. Despite developments in diagnosis/prognosis refinement and treatment modalities, the recurrence rate is high, and progression from non-muscle to muscle invasive UBC commonly leads to metastasis. Moreover, patients with muscle-invasive or extra-vesical disease often fail the standard chemotherapy treatment, and overall survival rates are poor. Thus, UBC remains a challenge in the oncology field, representing an ideal candidate for research on biomarkers that could identify patients at increased risk of recurrence, progression, and chemo-refractoriness. However, progress toward personalized medicine has been hampered by the unique genetic complexity of UBC. Recent genome-wide expression and sequencing studies have brought new insights into its molecular features, pathogenesis and clinical diversity, revealing a landscape where classical pathology is intersected by the novel and heterogeneous molecular groups. Hence, it seems plausible to postulate that only an integrated signature of prognostic/predictive biomarkers inherent in different cancer hallmarks will reach clinical validation. In this review, we have summarized ours and others' research into novel putative biomarkers of progression and chemoresistance that encompass several hallmarks of cancer: tumor neovascularization, invasion and metastasis, and energy metabolism reprogramming of the tumor microenvironment.
publishDate 2014
dc.date.none.fl_str_mv 2014-12-18
2014-12-18T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/40239
url http://hdl.handle.net/1822/40239
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv 2394-4722
http://www.jcmtjournal.com/article.asp?issn=2394-4722;year=2015;volume=1;issue=2;spage=57;epage=66;aulast=Afonso
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv OAE Publishing Inc. (OAE)
publisher.none.fl_str_mv OAE Publishing Inc. (OAE)
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833595536229269504